- Home
- CSGS vs IRON Comparison
CSGS vs IRON Comparison
Compare CSGS & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- IRON
- Stock Information
- Founded
- CSGS 1994
- IRON 2017
- Country
- CSGS United States
- IRON United States
- Employees
- CSGS N/A
- IRON N/A
- Industry
- CSGS EDP Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- CSGS Technology
- IRON Health Care
- Exchange
- CSGS Nasdaq
- IRON Nasdaq
- Market Cap
- CSGS 1.9B
- IRON 2.1B
- IPO Year
- CSGS 1996
- IRON N/A
- Fundamental
- Price
- CSGS $64.64
- IRON $70.28
- Analyst Decision
- CSGS Buy
- IRON Strong Buy
- Analyst Count
- CSGS 8
- IRON 10
- Target Price
- CSGS $68.86
- IRON $97.80
- AVG Volume (30 Days)
- CSGS 231.7K
- IRON 347.5K
- Earning Date
- CSGS 11-05-2025
- IRON 11-11-2025
- Dividend Yield
- CSGS 1.98%
- IRON N/A
- EPS Growth
- CSGS 30.24
- IRON N/A
- EPS
- CSGS 2.89
- IRON N/A
- Revenue
- CSGS $1,208,376,000.00
- IRON N/A
- Revenue This Year
- CSGS $4.82
- IRON N/A
- Revenue Next Year
- CSGS $3.19
- IRON N/A
- P/E Ratio
- CSGS $22.37
- IRON N/A
- Revenue Growth
- CSGS 3.31
- IRON N/A
- 52 Week Low
- CSGS $46.17
- IRON $30.82
- 52 Week High
- CSGS $67.60
- IRON $72.68
- Technical
- Relative Strength Index (RSI)
- CSGS 46.76
- IRON 67.33
- Support Level
- CSGS $63.26
- IRON $67.31
- Resistance Level
- CSGS $65.24
- IRON $69.87
- Average True Range (ATR)
- CSGS 1.16
- IRON 2.40
- MACD
- CSGS -0.24
- IRON 0.47
- Stochastic Oscillator
- CSGS 23.19
- IRON 83.99
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.